drugset / Trial / NCT03046407
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells
Phase 1/2
Unknown
10 enrolled
Chinese Academy of Sciences
The First Affiliated Hospital of Zhengzhou University · collab
NaSingle-groupOpen-labelOther
Summary
This project intends to transplant human embryonic stem cells derived retinal pigment epitheliums into subretinal space of patients to treat dry age-related macular degeneration(dry-AMD).And we will assess the safety and efficacy of RPE transplants to treat dry AMD.
Timeline
- Start
- 2017-09-06
- Primary completion
- 2019-01
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | retinal pigment epithelium | Cell therapy | — | Other |